Abstract
K2P channel is the leaky potassium channel that is critical to keep up the negative resting membrane potential for legitimate electrical conductivity of the excitable tissues. Recently, many substances and medication elements are discovered that could either straightforwardly or in a roundabout way influence the 15 distinctive K+ ion channels including TWIK, TREK, TASK, TALK, THIK, and TRESK. Opening and shutting of these channels or any adjustment in their conduct is thought to alter the pathophysiological condition of CNS. There is no document available till now to explain in detail about the molecular mechanism of agents acting on K2P channel. Accordingly, in this review we cover the current research and mechanism of action of these channels, we have also tried to mention the detailed effect of drugs and how the channel behavior changes by focusing on recent advances regarding activation and modulation of ion channels.
Graphic Abstract
Similar content being viewed by others
Change history
22 March 2022
A Correction to this paper has been published: https://doi.org/10.1007/s00232-022-00229-x
References
Abraham DM, Lee TE, Watson LJ, Mao L, Chandok G, Wang HG, Frangakis S, Pitt GS, Shah SH, Wolf MJ, Rockman HA (2018) The two-pore domain potassium channel TREK-1 mediates cardiac fibrosis and diastolic dysfunction. J Clin Invest 128:4843–4855
Acosta C, Djouhri L, Watkins R, Berry C, Bromage K, Lawson SN (2014) TREK2 expressed selectively in IB4-binding C-fiber nociceptors hyperpolarizes their membrane potentials and limits spontaneous pain. J Neurosci 34:1494–1509
Akhondzadeh S, Mojtahedzadeh V, Mirsepassi GR, Moin M, Amini-Nooshabadi H, Kamalipour A (2002) Diazoxide in the treatment of schizophrenia: novel application of potassium channel openers in the treatment of schizophrenia. J Clin Pharm Ther 27:453–459
Aller MI, Wisden W (2008) Changes in expression of some two-pore domain potassium channel genes (KCNK) in selected brain regions of developing mice. Neuroscience 151:1154–1172
Alloui A, Zimmermann K, Mamet J, Duprat F, Noël J, Chemin J, Guy N, Blondeau N, Voilley N, Rubat-Coudert C, Borsotto M, Romey G, Heurteaux C, Reeh P, Eschalier A, Lazdunski M (2006) TREK-1, a K+ channel involved in polymodal pain perception. EMBO J 25:2368–2376
Andres-Bilbe A, Castellanos A, Pujol-Coma A, Callejo G, Comes N, Gasull X (2020) The Background K(+) Channel TRESK in Sensory Physiology and Pain. Int J Mol Sci 21:5206
Askland K, Read C, O’Connell C, Moore JH (2012) Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing. Hum Genet 131:373–391
Bedoya M, Rinné S, Kiper AK, Decher N, González W, Ramírez D (2019) TASK channels pharmacology: new challenges in drug design. J Med Chem 62:10044–10058
Berg AP, Talley EM, Manger JP, Bayliss DA (2004) Motoneurons express heteromeric TWIK-related acid-sensitive K+ (TASK) channels containing TASK-1 (KCNK3) and TASK-3 (KCNK9) subunits. J Neurosci 24:6693–6702
Blin S, Chatelain FC, Feliciangeli S, Kang D, Lesage F, Bichet D (2014) Tandem pore domain halothane-inhibited K+ channel subunits THIK1 and THIK2 assemble and form active channels. J Biol Chem 289:28202–28212
Borsotto M, Veyssiere J, Moha Ou Maati H, Devader C, Mazella J, Heurteaux C (2015) Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept. Br J Pharmacol 172:771–784
Callejo G, Giblin JP, Gasull X (2013) Modulation of TRESK background K+ channel by membrane stretch. PLoS ONE 8:e64471
Chavez RA, Gray AT, Zhao BB, Kindler CH, Mazurek MJ, Mehta Y, Forsayeth JR, Yost CS (1999) TWIK-2, a new weak inward rectifying member of the tandem pore domain potassium channel family. J Biol Chem 274:7887–7892
Chen X, Talley EM, Patel N, Gomis A, McIntire WE, Dong B, Viana F, Garrison JC, Bayliss DA (2006a) Inhibition of a background potassium channel by Gq protein alpha-subunits. Proc Natl Acad Sci U S A 103:3422–3427
Chen X, Talley EM, Patel N, Gomis A, McIntire WE, Dong B, Viana F, Garrison JC, Bayliss DA (2006b) Inhibition of a background potassium channel by Gq protein α-subunits. Proc Natl Acad Sci 103:3422–3427
Cotten JF (2013) TASK-1 (KCNK3) and TASK-3 (KCNK9) tandem pore potassium channel antagonists stimulate breathing in isoflurane anesthetized rats. Anesth Analg 116:e3182844
Czirják G, Petheo GL, Spät As, Enyedi P (2001) Inhibition of TASK-1 potassium channel by phospholipase C. Am J Physiol Cell Physiol 281:C700–C708
De Franco E, Flanagan SE, Houghton JA, Lango Allen H, Mackay DJ, Temple IK, Ellard S, Hattersley AT (2015) The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet 386:957–963
Decher N, Maier M, Dittrich W, Gassenhuber J, Brüggemann A, Busch AE, Steinmeyer K (2001) Characterization of TASK-4, a novel member of the pH-sensitive, two-pore domain potassium channel family. FEBS Lett 492:84–89
Dong YY, Pike AC, Mackenzie A, McClenaghan C, Aryal P, Dong L, Quigley A, Grieben M, Goubin S, Mukhopadhyay S, Ruda GF, Clausen MV, Cao L, Brennan PE, Burgess-Brown NA, Sansom MS, Tucker SJ, Carpenter EP (2015) K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac. Science 347:1256–1259
Dragicevic E, Schiemann J, Liss B (2015) Dopamine midbrain neurons in health and Parkinson’s disease: emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels. Neuroscience 284:798–814
Duprat F, Lesage F, Patel AJ, Fink M, Romey G, Lazdunski M (2000) The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK. Mol Pharmacol 57:906–912
Enyedi P, Czirják G (2010) Molecular background of leak K+ currents: two-pore domain potassium channels. Physiol Rev 90:559–605
Ferrari U, Empl M, Kim KS, Sostak P, Förderreuther S, Straube A (2005) Calcineurin inhibitor-induced headache: clinical characteristics and possible mechanisms. Headache 45:211–214
Fink M, Lesage F, Duprat F, Heurteaux C, Reyes R, Fosset M, Lazdunski M (1998) A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J 17:3297–3308
Gada K, Plant LD (2019) Two-pore domain potassium channels: emerging targets for novel analgesic drugs: IUPHAR review 26. Br J Pharmacol 176:256–266
Gerstin KM, Gong DH, Abdallah M, Winegar BD, Eger EI 2nd, Gray AT (2003) Mutation of KCNK5 or Kir3.2 potassium channels in mice does not change minimum alveolar anesthetic concentration. Anesth Analg 96:1345–1349
Girard C, Duprat F, Terrenoire C, Tinel N, Fosset M, Romey G, Lazdunski M, Lesage F (2001) Genomic and functional characteristics of novel human pancreatic 2P domain K+ channels. Biochem Biophys Res Commun 282:249–256
Hall AM, Throesch BT, Buckingham SC, Markwardt SJ, Peng Y, Wang Q, Hoffman DA, Roberson ED (2015) Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer’s disease. J Neurosci 35:6221–6230
Hervieu GJ, Cluderay JE, Gray CW, Green PJ, Ranson JL, Randall AD, Meadows HJ (2001) Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS. Neuroscience 103:899–919
Heurteaux C, Guy N, Laigle C, Blondeau N, Duprat F, Mazzuca M, Lang-Lazdunski L, Widmann C, Zanzouri M, Romey G, Lazdunski M (2004) TREK-1, a K+ channel involved in neuroprotection and general anesthesia. Embo j 23:2684–2695
Heurteaux C, Lucas G, Guy N, El Yacoubi M, Thümmler S, Peng XD, Noble F, Blondeau N, Widmann C, Borsotto M, Gobbi G, Vaugeois JM, Debonnel G, Lazdunski M (2006) Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci 9:1134–1141
Huang H, Li H, Shi K, Wang L, Zhang X, Zhu X (2018) TREK-TRAAK two-pore domain potassium channels protect human retinal pigment epithelium cells from oxidative stress. Int J Mol Med 42:2584–2594
Hughes S, Foster RG, Peirson SN, Hankins MW (2017) Expression and localisation of two-pore domain (K2P) background leak potassium ion channels in the mouse retina. Sci Rep 7:1–14
Humphries ES, Dart C (2015) Neuronal and cardiovascular potassium channels as therapeutic drug targets: promise and pitfalls. J Biomol Screen 20:1055–1073
Kanda H, Ling J, Tonomura S, Noguchi K, Matalon S, Gu JG (2019) TREK-1 and TRAAK are principal K+ channels at the nodes of ranvier for rapid action potential conduction on mammalian myelinated afferent nerves. Neuron 104:960-971.e7
Kang D, Hogan JO, Kim D (2014) THIK-1 (K2P13.1) is a small-conductance background K(+) channel in rat trigeminal ganglion neurons. Pflugers Arch 466:1289–1300
Kasianowicz JJ (2012) Introduction to ion channels and disease. Chem Rev 112:6215–6217
Kim D (2005) Physiology and pharmacology of two-pore domain potassium channels. Curr Pharm Des 11:2717–2736
Kim D, Cavanaugh EJ, Kim I, Carroll JL (2009) Heteromeric TASK-1/TASK-3 is the major oxygen-sensitive background K+ channel in rat carotid body glomus cells. J Physiol 587:2963–2975
Kim Y, Gnatenco C, Bang H, Kim D (2001) Localization of TREK-2 K+ channel domains that regulate channel kinetics and sensitivity to pressure, fatty acids and pHi. Pflugers Arch 442:952–960
Kim DS, Kim JE, Kwak SE, Choi HC, Song HK, Kimg YI, Choi SY, Kang TC (2007) Up-regulated astroglial TWIK-related acid-sensitive K+ channel-1 (TASK-1) in the hippocampus of seizure-sensitive gerbils: a target of anti-epileptic drugs. Brain Res 1185:346–358
Kindler CH, Yost CS (2005) Two-pore domain potassium channels: new sites of local anesthetic action and toxicity. Reg Anesth Pain Med 30:260–274
Kindler CH, Yost SC, Gray AT (1999) Local anesthetic inhibition of baseline potassium channels with two pore domains in tandem. J Am Soc Anesthesiol 90:1092–1102
Lafrenière RG, Rouleau GA (2011) Migraine: role of the TRESK two-pore potassium channel. Int J Biochem Cell Biol 43:1533–1536
Lafrenière RG, Cader MZ, Poulin J-F, Andres-Enguix I, Simoneau M, Gupta N, Boisvert K, Lafrenière F, McLaughlan S, Dubé M-P (2010) A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med 16:1157–1160
Lamas JA, Fernández-Fernández D (2019) Tandem pore TWIK-related potassium channels and neuroprotection. Neural Regen Res 14:1293–1308
Lazarenko RM, Willcox SC, Shu S, Berg AP, Jevtovic-Todorovic V, Talley EM, Chen X, Bayliss DA (2010) Motoneuronal TASK channels contribute to immobilizing effects of inhalational general anesthetics. J Neurosci 30:7691–7704
Lee A, Smart J, Rubinstein M, Low M, Tse A (2011a) Reciprocal regulation of TREK-1 channels by arachidonic acid and CRH in mouse corticotropes. Endocrinology 152:1901–1910
Lengyel M, Czirják G, Jacobson DA, Enyedi P (2020) TRESK and TREK-2 two-pore-domain potassium channel subunits form functional heterodimers in primary somatosensory neurons. J Biol Chem 295:12408–12425
Lim CX, Ricos MG, Dibbens LM, Heron SE (2016) KCNT1 mutations in seizure disorders: the phenotypic spectrum and functional effects. J Med Genet 53:217–225
Lin DH, Zhang XR, Ye DQ, Xi GJ, Hui JJ, Liu SS, Li LJ, Zhang ZJ (2015) The role of the two-pore domain potassium channel TREK-1 in the therapeutic effects of escitalopram in a rat model of poststroke depression. CNS Neurosci Ther 21:504–512
Linden AM, Sandu C, Aller MI, Vekovischeva OY, Rosenberg PH, Wisden W, Korpi ER (2007) TASK-3 knockout mice exhibit exaggerated nocturnal activity, impairments in cognitive functions, and reduced sensitivity to inhalation anesthetics. J Pharmacol Exp Ther 323:924–934
Lindner M, Leitner MG, Halaszovich CR, Hammond GR, Oliver D (2011) Probing the regulation of TASK potassium channels by PI (4, 5) P2 with switchable phosphoinositide phosphatases. J Physiol 589:3149–3162
Lopes CM, Rohács T, Czirják G, Balla T, Enyedi P, Logothetis DE (2005) PIP2 hydrolysis underlies agonist-induced inhibition and regulates voltage gating of two-pore domain K+ channels. J Physiol 564:117–129
Lotshaw DP (2007) Biophysical, pharmacological, and functional characteristics of cloned and native mammalian two-pore domain K+ channels. Cell Biochem Biophys 47:209–256
Maingret F, Patel AJ, Lesage F, Lazdunski M, Honoré E (2000) Lysophospholipids open the two-pore domain mechano-gated K(+) channels TREK-1 and TRAAK. J Biol Chem 275:10128–10133
Marsh B, Acosta C, Djouhri L, Lawson SN (2012) Leak K+ channel mRNAs in dorsal root ganglia: relation to inflammation and spontaneous pain behaviour. Mol Cell Neurosci 49:375–386
Mathie A (2007) Neuronal two-pore-domain potassium channels and their regulation by G protein-coupled receptors. J Physiol 578:377–385
Mathie A, Veale E (2007a) Therapeutic potential of neuronal two-pore domain potassium-channel modulators. Curr Opin Invest Drugs 8:555–562
Mathie A, Veale EL (2007b) Therapeutic potential of neuronal two-pore domain potassium-channel modulators. Curr Opin Investig Drugs 8:555–562
Meadows HJ, Benham CD, Cairns W, Gloger I, Jennings C, Medhurst AD, Murdock P, Chapman CG (2000) Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel. Pflugers Arch 439:714–722
Medhurst AD, Rennie G, Chapman CG, Meadows H, Duckworth MD, Kelsell RE, Gloger II, Pangalos MN (2001) Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. Brain Res Mol Brain Res 86:101–114
Meuth SG, Aller MI, Munsch T, Schuhmacher T, Seidenbecher T, Meuth P, Kleinschnitz C, Pape HC, Wiendl H, Wisden W, Budde T (2006) The contribution of TWIK-related acid-sensitive K+-containing channels to the function of dorsal lateral geniculate thalamocortical relay neurons. Mol Pharmacol 69:1468–1476
Millar JA, Barratt L, Southan AP, Page KM, Fyffe REW, Robertson B, Mathie A (2000) A functional role for the two-pore domain potassium channel TASK-1 in cerebellar granule neurons. Proc Natl Acad Sci 97:3614–3618
Miller AN, Long SB (2012) Crystal structure of the human two-pore domain potassium channel K2P1. Science 335:432–436
Nagaraj C, Tang B, Bálint Z, Wygrecka M, Hrzenjak A, Kwapiszewska G, Stacher E, Lindenmann J, Weir EK, Olschewski H (2013) Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries. Eur Respir J 41:85–95
Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (eds) (2012) Jasper’s basic mechanisms of the epilepsies. National Center for Biotechnology Information (US) In: Rogawski MA, Delgado-Escueta AV, Noebels JL, Avoli M, Olsen RW Bethesda (MD)
Patel AJ, Honoré E, Lesage F, Fink M, Romey G, Lazdunski M (1999) Inhalational anesthetics activate two-pore-domain background K+ channels. Nat Neurosci 2:422–426
Patel AJ, Honoré E, Maingret F, Lesage F, Fink M, Duprat F, Lazdunski M (1998) A mammalian two pore domain mechano-gated S-like K+ channel. EMBO J 17:4283–4290
Patel AJ, Maingret F, Magnone V, Fosset M, Lazdunski M, Honoré E (2000) TWIK-2, an inactivating 2P domain K+ channel. J Biol Chem 275:28722–28730
Pereira C, Martins LM, Saraiva L (2014) LRRK2, but not pathogenic mutants, protects against H2O2 stress depending on mitochondrial function and endocytosis in a yeast model. Biochim Biophys Acta 1840:2025–2031
Putzke C, Hanley PJ, Schlichthorl G, Preisig-Muller R, Rinne S, Anetseder M, Eckenhoff R, Berkowitz C, Vassiliou T, Wulf H (2007a) Differential effects of volatile and intravenous anesthetics on the activity of human TASK-1. Am J Physiol Cell Physiol 293:C1319–C1326
Putzke C, Wemhöner K, Sachse FB, Rinné S, Schlichthörl G, Li XT, Jaé L, Eckhardt I, Wischmeyer E, Wulf H (2007b) The acid-sensitive potassium channel TASK-1 in rat cardiac muscle. Cardiovasc Res 75:59–68
Rajan S, Wischmeyer E, Karschin C, Preisig-Müller R, Grzeschik K-H, Daut J, Karschin A, Derst C (2001) THIK-1 and THIK-2, a novel subfamily of tandem pore domain K+ channels*210. J Biol Chem 276:7302–7311
Renigunta V, Zou X, Kling S, Schlichthörl G, Daut J (2014) Breaking the silence: functional expression of the two-pore-domain potassium channel THIK-2. Pflugers Arch 466:1735–1745
Ru Q, Tian X, Wu YX, Wu RH, Pi MS, Li CY (2014) Voltage-gated and ATP-sensitive K+ channels are associated with cell proliferation and tumorigenesis of human glioma. Oncol Rep 31:842–848
Schiekel J, Lindner M, Hetzel A, Wemhöner K, Renigunta V, Schlichthörl G, Decher N, Oliver D, Daut J (2013) The inhibition of the potassium channel TASK-1 in rat cardiac muscle by endothelin-1 is mediated by phospholipase C. Cardiovasc Res 97:97–105
Schroeder BC, Kubisch C, Stein V, Jentsch TJ (1998) Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. Nature 396:687–690
Sepúlveda FV, Pablo Cid L, Teulon J, Niemeyer MI (2015) Molecular aspects of structure, gating, and physiology of pH-sensitive background K2P and Kir K+-transport channels. Physiol Rev 95:179–217
Seyler C, Duthil-Straub E, Zitron E, Gierten J, Scholz EP, Fink R, Karle C, Becker R, Katus H, Thomas D (2012) TASK1 (K2P3. 1) K+ channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation. Br J Pharmacol 165:1467–1475
Sirois JE, Lei Q, Talley EM, Lynch C 3rd, Bayliss DA (2000) The TASK-1 two-pore domain K+ channel is a molecular substrate for neuronal effects of inhalation anesthetics. J Neurosci 20:6347–6354
Talley EM, Solorzano G, Lei Q, Kim D, Bayliss DA (2001) Cns distribution of members of the two-pore-domain (KCNK) potassium channel family. J Neurosci 21:7491–7505
Thümmler S, Duprat F, Lazdunski M (2007) Antipsychotics inhibit TREK but not TRAAK channels. Biochem Biophys Res Commun 354:284–289
Tong L, Cai M, Huang Y, Zhang H, Su B, Li Z, Dong H (2014) Activation of K2P channel–TREK1 mediates the neuroprotection induced by sevoflurane preconditioning. British J Anaesth 113:157–167
Veale EL, Buswell R, Clarke CE, Mathie A (2007) Identification of a region in the TASK3 two pore domain potassium channel that is critical for its blockade by methanandamide. Br J Pharmacol 152:778–786
Verkest, C, Häfner, S, Ávalos Prado, P, Baron, A, Sandoz, G (2020). Migraine and Two-Pore-Domain Potassium Channels. Neuroscientist. https://doi.org/10.1177/1073858420940949
Vukadinovic Z, Rosenzweig I (2012) Abnormalities in thalamic neurophysiology in schizophrenia: could psychosis be a result of potassium channel dysfunction? Neurosci Biobehav Rev 36:960–968
Wang G, Zeng J, Ren R, Chen S (2008) Potassium channels in the basal ganglia: promising new targets for the treatment of Parkinson’s disease. Front Biosci 13:3825–3838
Wickenden AD (2002) Potassium channels as anti-epileptic drug targets. Neuropharmacology 43:1055–1060
Wilke BU, Lindner M, Greifenberg L, Albus A, Kronimus Y, Bünemann M, Leitner MG, Oliver D (2014) Diacylglycerol mediates regulation of TASK potassium channels by Gq-coupled receptors. Nat Commun 5:1–11
Wu F, Sun H, Gong W, Li X, Pan Z, Shan H, Zhang Z (2021) Genetic and pharmacological inhibition of two-pore domain potassium channel TREK-1 alters depression-related behaviors and neuronal plasticity in the hippocampus in mice. CNS Neurosci Ther 27:220–232
Xu X, Pan Y, Wang X (2004) Alterations in the expression of lipid and mechano-gated two-pore domain potassium channel genes in rat brain following chronic cerebral ischemia. Brain Res Mol Brain Res 120:205–209
Yang J, Jan YN, Jan LY (1995) Determination of the subunit stoichiometry of an inwardly rectifying potassium channel. Neuron 15:1441–1447
Yeh CY, Bulas AM, Moutal A, Saloman JL, Hartnett KA, Anderson CT, Tzounopoulos T, Sun D, Khanna R, Aizenman E (2017) Targeting a potassium channel/syntaxin interaction ameliorates cell death in ischemic stroke. J Neurosci 37:5648–5658
Young CC, Stegen M, Bernard R, Müller M, Bischofberger J, Veh RW, Haas CA, Wolfart J (2009) Upregulation of inward rectifier K+ (Kir2) channels in dentate gyrus granule cells in temporal lobe epilepsy. J Physiol 587:4213–4233
Yoo S, Liu J, Sabbadini M, Au P, Xie G-x, Yost CS (2009) Regional expression of the anesthetic-activated potassium channel TRESK in the rat nervous system. Neurosci Lett 465:79–84
Yost CS (2003) Update on tandem pore (2P) domain K+ channels. Curr Drug Targets 4:347–351
Yost CS, Oh I, Eger EI, Sonner JM (2008) Knockout of the gene encoding the K2P channel KCNK7 does not alter volatile anesthetic sensitivity. Behav Brain Res 193:192–196
Zhang J, Kim EC, Chen C, Procko E, Pant S, Lam K, Patel J, Choi R, Hong M, Joshi D (2020) Identifying mutation hotspots reveals pathogenetic mechanisms of KCNQ2 epileptic encephalopathy. Sci Rep 10:1–19
Zhang L, Li X, Zhou R, Xing G (2006) Possible role of potassium channel, big K in etiology of schizophrenia. Med Hypotheses 67:41–43
Acknowledgements
Author is thankful to the department of Pharmaceuticals, Ministry of Chemical and Fertilizers, Govt. of India, for providing necessary support to carry out this study.
Funding
No Funding has been received for this work.
Author information
Authors and Affiliations
Contributions
VR and PA designed the research. SS wrote the manuscript. All authors read and edited the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing financial interest.
Ethical Approval
No animal or human study done in this work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: In this article, the order that the authors appeared in the author list was incorrect. Also, the author name ‘Punita Aggarwal’ was incorrectly written as ‘Punita Agarwal’.
Rights and permissions
About this article
Cite this article
Aggarwal, P., Singh, S. & Ravichandiran, V. Two-Pore Domain Potassium Channel in Neurological Disorders. J Membrane Biol 254, 367–380 (2021). https://doi.org/10.1007/s00232-021-00189-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-021-00189-8